Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2017 on February 9, 2017

BOULDER, Colo., Feb. 2, 2017 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) will report financial results for the second quarter of fiscal 2017 and hold a conference call to discuss those results on Thursday, February 9, 2017.  Ron Squarer, Chief Executive Officer, will lead the call.


Thursday, February 9, 2017


9:00 a.m. Eastern Time


(844) 464-3927


(765) 507-2598

Pass Code:


Webcast, including Replay and Conference Call Slides:

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).


Tricia Haugeto

Array BioPharma Inc.

(303) 386-1193


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.

ShareThis Copy and Paste